Tumor fraction-guided cell-free DNA profiling in metastatic solid tumor patients

Overview of attention for article published in Genome Medicine, May 2021

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 12 X posts from 12 X users, with an upper bound of 75,871 followers.

RT @CDebyaniPhD: Published in @BioMedCentral by @DNA_tsui & @DSolit https://t.co/ET7QQjvnn6 cfDNA is helpful for pts w/ hard to biopsy met…

RT @CDebyaniPhD: Published in @BioMedCentral by @DNA_tsui & @DSolit https://t.co/ET7QQjvnn6 cfDNA is helpful for pts w/ hard to biopsy met…

RT @CDebyaniPhD: Published in @BioMedCentral by @DNA_tsui & @DSolit https://t.co/ET7QQjvnn6 cfDNA is helpful for pts w/ hard to biopsy met…

RT @BenWestphalen: In @GenomeMedicine - data from the @sloan_kettering IMPCAT program. Data from 118 patients makes an argument to assess…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 8 additional X posts.